181 related articles for article (PubMed ID: 25395832)
21. Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.
Qian C; Li M; Sui J; Ren T; Li Z; Zhang L; Zhou L; Cheng Y; Wang D
Drug Des Devel Ther; 2014; 8():485-96. PubMed ID: 24872679
[TBL] [Abstract][Full Text] [Related]
22. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
24. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
25. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
27. Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation.
Song YJ; Lee JY; Joo HK; Kim HS; Lee SK; Lee KH; Cho CH; Park JB; Jeon BH
Biochem Biophys Res Commun; 2008 Mar; 368(1):68-73. PubMed ID: 18206643
[TBL] [Abstract][Full Text] [Related]
28. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
[TBL] [Abstract][Full Text] [Related]
29. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP
Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411
[TBL] [Abstract][Full Text] [Related]
30. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
[TBL] [Abstract][Full Text] [Related]
31. Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.
Guerreiro PS; Estácio SG; Antunes F; Fernandes AS; Pinheiro PF; Costa JG; Castro M; Miranda JP; Guedes RC; Oliveira NG
Chem Biol Drug Des; 2016 Dec; 88(6):915-925. PubMed ID: 27450574
[TBL] [Abstract][Full Text] [Related]
32. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
Zou GM; Maitra A
Mol Cancer Ther; 2008 Jul; 7(7):2012-21. PubMed ID: 18645011
[TBL] [Abstract][Full Text] [Related]
33. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
35. Diverse small molecule inhibitors of human apurinic/apyrimidinic endonuclease APE1 identified from a screen of a large public collection.
Dorjsuren D; Kim D; Vyjayanti VN; Maloney DJ; Jadhav A; Wilson DM; Simeonov A
PLoS One; 2012; 7(10):e47974. PubMed ID: 23110144
[TBL] [Abstract][Full Text] [Related]
36. Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions.
Jiang Y; Guo C; Fishel ML; Wang ZY; Vasko MR; Kelley MR
DNA Repair (Amst); 2009 Nov; 8(11):1273-82. PubMed ID: 19726241
[TBL] [Abstract][Full Text] [Related]
37. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
38. Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells.
Kim CS; Son SJ; Kim EK; Kim SN; Yoo DG; Kim HS; Ryoo SW; Lee SD; Irani K; Jeon BH
Cardiovasc Res; 2006 Feb; 69(2):520-6. PubMed ID: 16325162
[TBL] [Abstract][Full Text] [Related]
39. Small molecule activation of apurinic/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons.
Georgiadis MM; Chen Q; Meng J; Guo C; Wireman R; Reed A; Vasko MR; Kelley MR
DNA Repair (Amst); 2016 May; 41():32-41. PubMed ID: 27078577
[TBL] [Abstract][Full Text] [Related]
40. Human AP endonuclease/redox factor APE1/ref-1 modulates mitochondrial function after oxidative stress by regulating the transcriptional activity of NRF1.
Li M; Vascotto C; Xu S; Dai N; Qing Y; Zhong Z; Tell G; Wang D
Free Radic Biol Med; 2012 Jul; 53(2):237-48. PubMed ID: 22580151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
